Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
77
datasets available to search
ShareScore release 0.7.1
Dataset results
77 results for “Primary brain tumor”
Suramin in Treating Patients With Recurrent Primary Brain Tumors
ClinicalTrials.gov study NCT00002639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
ClinicalTrials.gov study NCT00003484. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients
ClinicalTrials.gov study NCT00876499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors
ClinicalTrials.gov study NCT00002754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy
ClinicalTrials.gov study NCT00463203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer
ClinicalTrials.gov study NCT06449989. IPD Sharing: YES. Countries: 1. Publications: 0.
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
ClinicalTrials.gov study NCT00003461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
ClinicalTrials.gov study NCT06439420. IPD Sharing: NO. Countries: 1. Publications: 0.
Differentially expression profiling in a brain metastasis of a papillary thyroid carcinoma and its technical replicate vs. non-brain metastatic papillary thyroid carcinomas, and primary brain tumors
GEO Series GSE66463. Homo sapiens. 18 samples. Type: Expression profiling by array.
Genome-wide DNA methylation profiling of 68 GBM (primary & recurrent), 4 glioma spheres and 5 non-tumor brain samples
GEO Series GSE60274. Homo sapiens. 77 samples. Type: Methylation profiling by genome tiling array.
Expression profiling in breast cancer brain metastases compared to breast cancers and primary brain tumors
GEO Series GSE100534. Homo sapiens. 35 samples. Type: Expression profiling by array.
Integrated genomics identifies a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors
GEO Series GSE65132. Homo sapiens. 9 samples. Type: Expression profiling by array.
Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
ClinicalTrials.gov study NCT00004659. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Microbial signals in primary and metastatic brain tumors
GEO Series GSE305267. Homo sapiens. 368 samples. Type: Other.
Microbial signals in primary and metastatic brain tumors [CosMx]
GEO Series GSE305393. Homo sapiens. 2 samples. Type: Other.
Dataset related to article "Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform"
<p>This record contains raw data related to article "Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform"</p><p>Abstract</p><p>Background: Comparative prospective data regarding different radiosurgery (SRS) modalities for treating brain metastases (BMs) from solid tumors are not available. To investigate with a single institute phase III randomized trial whether SRS executed with linac (Arm-B) is superior to a dedicated multi-source gamma-ray stereotactic platform (Arm-A).</p><p>Methods: Adults patients with 1-4 BMs from solid tumors up to 30 mm in maximum diameter were randomly assigned to arms A and B. The primary endpoint was cumulative incidence of symptomatic (grade 2-3) radionecrosis (CIRN). Secondary endpoints were local progression cumulative incidence (CILP), distant brain failure, disease-free survival (DFS), and overall survival (OS).</p><p>Results: A total of 251 patients were randomly assigned to Arm-A (121) or Arm-B (130). The 1-year RN cumulative incidence was 6.7% in whole cohort, 3.8% (95% CI 1.9-7.4%) in Arm-B, and 9.3% (95% CI 6.2-13.8%) in the Arm-A (p = 0.43). CIRN was influenced by target volume irradiated only for the Arm-A (p << 0.001; HR 1.36 [95% CI 1.25-1.48]). Symptomatic RN occurred in 56 cases at a median time of 10.3 months (range 1.15-54.8 months), 27 in the Arm-B at a median time of 15.9 months (range 4.9-54.8 months), and 29 in the Arm-A at a median time of 6.9 months (1.2-32.3 months), without statistically significant differences between the two arms. No statistically significant differences were recorded between the two arms in CILP, BDF, DFS or OS. The mean beam-on time to deliver SRS was 49.0 ± 36.2 min in Arm-A, and 3.1 ± 1.6 min in Arm-B.</p><p>Conclusions: Given the technical differences between the treatment platforms investigated in this single-institution study, linac-based SRS (Arm-B) did not lead to significantly lower grade 2-3 RN rates versus the multi-source gamma-ray system (Arm-A) in a population of patients with limited brain metastases of small volume. No significant difference in local control was observed between both arms. For Arm-B, the treatment delivery time was significantly lower than for Arm-A.</p><p> </p><p>Trial registration: ClinicalTrials.gov Identifier NCT02355613.</p><p> </p>
Gene expression analysis of murine 4T1 breast cancer cells derived from primary tumor, lung metastasis and brain metastasis
GEO Series GSE54773. Mus musculus. 9 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.